Faculty Opinions recommendation of Alternative donor transplantation for older patients with acute myeloid leukemia in first complete remission: a center for international blood and marrow transplant research-eurocord analysis.

Alternative Donor Transplantation for Older Patients with Acute Myeloid Leukemia in First Complete Remission: A Center for International Blood and Marrow Transplant Research-Eurocord Analysis

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2014.02.020 ◽

2014 ◽

Vol 20 (6) ◽

pp. 816-822 ◽

Cited By ~ 61

Author(s):

Daniel Weisdorf ◽

Mary Eapen ◽

Annalisa Ruggeri ◽

Mei-Jie Zhang ◽

Xiaobo Zhong ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Complete Remission ◽

Older Patients ◽

Myeloid Leukemia ◽

Marrow Transplant ◽

Blood And Marrow Transplant ◽

Alternative Donor ◽

Cytogenetic risk determines outcomes after allogeneic transplantation in older patients with acute myeloid leukemia in their second complete remission: A Center for International Blood and Marrow Transplant Research cohort analysis

Cancer ◽

10.1002/cncr.30567 ◽

2017 ◽

Vol 123 (11) ◽

pp. 2035-2042 ◽

Cited By ~ 5

Author(s):

Fotios V. Michelis ◽

Vikas Gupta ◽

Mei-Jie Zhang ◽

Hai-Lin Wang ◽

Mahmoud Aljurf ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Complete Remission ◽

Older Patients ◽

Myeloid Leukemia ◽

Cohort Analysis ◽

Allogeneic Transplantation ◽

Marrow Transplant ◽

Blood And Marrow Transplant ◽

Faculty Opinions recommendation of Effect of age on outcome of reduced-intensity hematopoietic cell transplantation for older patients with acute myeloid leukemia in first complete remission or with myelodysplastic syndrome.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.2813957.2479056 ◽

2010 ◽

Author(s):

Heidi Klepin

Keyword(s):

Acute Myeloid Leukemia ◽

Complete Remission ◽

Myelodysplastic Syndrome ◽

Older Patients ◽

Myeloid Leukemia ◽

Effect Of Age ◽

Reduced Intensity ◽

Role of alternative donor allogeneic hematopoietic stem cell transplantation in patients with intermediate- or poor-risk acute myeloid leukemia in first complete remission

Bone Marrow Transplantation ◽

10.1038/s41409-019-0571-8 ◽

2019 ◽

Vol 54 (12) ◽

pp. 2004-2012 ◽

Cited By ~ 3

Author(s):

Shingo Yano ◽

Hiroki Yokoyama ◽

Masamitsu Yanada ◽

Jinichi Mori ◽

Jun Aoki ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Stem Cell ◽

Hematopoietic Stem Cell Transplantation ◽

Complete Remission ◽

Myeloid Leukemia ◽

Hematopoietic Stem ◽

Alternative Donor ◽

Impact of depth of clinical response on outcomes of acute myeloid leukemia patients in first complete remission who undergo allogeneic hematopoietic cell transplantation

Bone Marrow Transplantation ◽

10.1038/s41409-021-01261-6 ◽

2021 ◽

Author(s):

Mary-Elizabeth Percival ◽

Hai-Lin Wang ◽

Mei-Jie Zhang ◽

Wael Saber ◽

Marcos de Lima ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Complete Remission ◽

Clinical Response ◽

Cell Transplantation ◽

Myeloid Leukemia ◽

Hematopoietic Cell ◽

Correction to: Impact of depth of clinical response on outcomes of acute myeloid leukemia patients in first complete remission who undergo allogeneic hematopoietic cell transplantation

Bone Marrow Transplantation ◽

10.1038/s41409-021-01353-3 ◽

2021 ◽

Author(s):

Mary-Elizabeth Percival ◽

Hai-Lin Wang ◽

Mei-Jie Zhang ◽

Wael Saber ◽

Marcos de Lima ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Complete Remission ◽

Clinical Response ◽

Cell Transplantation ◽

Myeloid Leukemia ◽

Hematopoietic Cell ◽

Allogeneic hematopoietic cell transplantation for acute myeloid leukemia in first complete remission after 5-azacitidine and venetoclax: a multicenter retrospective study

Annals of Hematology ◽

10.1007/s00277-021-04693-8 ◽

2021 ◽

Author(s):

Oren Pasvolsky ◽

Shai Shimony ◽

Ron Ram ◽

Avichai Shimoni ◽

Liat Shargian ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Retrospective Study ◽

Complete Remission ◽

Cell Transplantation ◽

Myeloid Leukemia ◽

Hematopoietic Cell ◽

Allogeneic hematopoietic cell transplantation compared to chemotherapy consolidation in older acute myeloid leukemia (AML) patients 60–75 years in first complete remission (CR1): an alliance (A151509), SWOG, ECOG-ACRIN, and CIBMTR study

Leukemia ◽

10.1038/s41375-019-0477-x ◽

2019 ◽

Vol 33 (11) ◽

pp. 2599-2609 ◽

Cited By ~ 13

Author(s):

Celalettin Ustun ◽

Jennifer Le-Rademacher ◽

Hai-Lin Wang ◽

Megan Othus ◽

Zhuoxin Sun ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Complete Remission ◽

Cell Transplantation ◽

Myeloid Leukemia ◽

Hematopoietic Cell ◽

Matched and mismatched unrelated donor compared to autologous stem cell transplantation for acute myeloid leukemia in first complete remission: a retrospective, propensity score-weighted analysis from the ALWP of the EBMT

Journal of Hematology & Oncology ◽

10.1186/s13045-016-0314-x ◽

2016 ◽

Vol 9 (1) ◽

Cited By ~ 21

Author(s):

Francesco Saraceni ◽

◽

Myriam Labopin ◽

Norbert-Claude Gorin ◽

Didier Blaise ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Stem Cell ◽

Complete Remission ◽

Propensity Score ◽

Stem Cell Transplantation ◽

Myeloid Leukemia ◽

Unrelated Donor ◽

Weighted Analysis ◽

Allogeneic stem cell transplantation for FLT3 mutated acute myeloid leukemia in first complete remission: does age really matter?

Haematologica ◽

10.3324/haematol.2017.186346 ◽

2018 ◽

Vol 103 (2) ◽

pp. 191-193 ◽

Cited By ~ 1

Author(s):

Stefan. O. Ciurea

Keyword(s):

Acute Myeloid Leukemia ◽

Stem Cell ◽

Complete Remission ◽

Stem Cell Transplantation ◽

Cell Transplantation ◽

Allogeneic Stem Cell Transplantation ◽

Myeloid Leukemia ◽